Jonathan I Lieber sold $3,992 of RLYB
Chief Financial Officer at Rallybio Corp. 789 shares at an average of $5.06, traded Feb 23, 2026, filed Feb 23, 2026.
Score components
- +22RoleCFO
- 0Trade size$4k at market
- +5Share of holdings soldSold 16% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +56.8%, 3m +188.7%, 6m +205.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001739410-26-000022, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | AGrant or award Common Stock | +2,500 | $0.00 | $0 | 4,904 | Feb 23, 2026 |
| Feb 23, 2026 | SOpen-market sale Common Stock | -789 | $5.06 | $3,992 | 4,115 | Feb 23, 2026 |
Related signals
Other insiders at Rallybio Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | RLYBbuy Rallybio Corp | ADAR1 Capital Management, LLC owner | $227k 16,209 shares | +2% | |
| 40Moderate | RLYBbuy Rallybio Corp | ADAR1 Capital Management, LLC owner | $1.1M 79,559 shares | +10% | |
| 36Weak | RLYBbuy Rallybio Corp | ADAR1 Capital Management, LLC owner | $711k 50,800 shares | +7% | |
| 38Weak | RLYBbuy Rallybio Corp | ADAR1 Capital Management, LLC owner | $2.2M 155,905 shares | +25% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.